WHO Critical Care Training for Tajik Clinicians
During the five-day workshop held in Dushanbe, the participants learned how to perform critical care management of severe acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome (ARDS), severe sepsis and septic shock, using a systematic, evidence-based approach.
The training course used a problem-solving approach to facilitate the learning of the principal components of critical care management of patients with severe forms of influenza infection. It was based on a participatory approach that offers the participants a step-by-step approach to acquire the knowledge and skills they need for the tasks involved – from hospital entry to discharge of patients suffering from severe influenza virus infection.
The trainers used different methods to conduct the workshop: short lectures using slides and small video clips, interactive role play sessions (in small groups of about 10 participants per facilitator), equipment and consumables for demonstration of infection prevention control rules and the use of a toolkit as a reference guide.
To measure participants’ knowledge of the course content, a test was conducted at the start and after completion of the course. In addition, the participants completed a survey at the end of each day to provide immediate feedback regarding learning environment, teaching materials, learning methods, and facilitators. Overall, the participants reported most learning sequences to be very good.
The clinical workshop was conducted through the joint efforts of WHO headquarters, WHO/Europe and the WHO Country Office in collaboration with Tajikistan’s Ministry of Health and Social Protection of the Population.
The WHO Country Office in Tajikistan was established in 1992 in Dushanbe to provide technical assistance to the Ministry of Health in strengthening of the public health system in the country. The country team consists of 24 staff members, including 12 experts in the fields of health policy and financing, immunisation and surveillance, epidemiology, communicable diseases, disaster preparedness and response, family and community health, nutrition, food safety and food security, mental health and environment and health.
The priorities for the Country Office are set out in the biennial collaborative agreement between WHO/Europe and the host country. The Office implements the agreement in close collaboration with national institutions and international partner agencies.
Image Credit: WHO/Europe
Published on : Fri, 30 Jan 2015
Print as PDF
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The technical and clinical reference standard for all B·R·A·H·M·S PCT assays. All clinical cut-offs and algorithms were developed based on B·R·A·H·M·S PCT sensitive KRYPTOR. Homogeneous immunoassay for the quantitative d